IP Library › Assignment 060558/0076
Patent Assignment
Reel/Frame 060558/0076

Confirmation of Name Change

Recorded: 2022-06-30 Pages: 9
Assignor
VISTAPHARM, INC.
Executed: 2022-06-30
Assignee
VISTAPHARM, LLC
200 CONNELL DRIVE, BERKELEY HEIGHTS, NEW JERSEY, 07922
Covered Properties (4)
Midodrine Hydrochloride Oral Solution and Uses Thereof
Application: 16/469,101 →
Publication: US 2020/0113851
Midodrine Hydrochloride Oral Solution and Uses Thereof
Application: 17/202,238 →
Publication: US 2021/0322345
Syringe
Patent: 836,772 →
Application: 29/657,824 →
Syringe
Patent: 851,757 →
Application: 29/668,705 →
Related Assignments (9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 20, 2018
From: NANDI, INDRANIL; HIPPALGAONKAR, KETAN; VANDSE, SUNIL
To: VERTICE PHARMA, LLC
Reel/Frame 046927/0651 →
Assignment of Assignor's Interest Nov 1, 2018
From: NANDI, INDRANIL; HIPPALGAONKAR, KETAN; VANDSE, SUNIL
To: VERTICE PHARMA, LLC
Reel/Frame 047383/0535 →
Assignment of Assignor's Interest Mar 10, 2020
From: NANDI, INDRANIL; HIPPALGAONKAR, KETAN; VANDSE, SUNIL; VACHHANI, RISH J.
To: VERTICE PHARMA, LLC
Reel/Frame 052074/0095 →
Patent Assignment Agreement Jun 30, 2022
From: VERTICE PHARMA, LLC
To: VISTAPHARM, INC.
Reel/Frame 060557/0561 →
Assignment of Assignor's Interest Aug 9, 2022
From: VERTICE PHARMA, LLC
To: AZURITY PHARMACEUTICALS, INC.
Reel/Frame 060758/0837 →
Assignment of Assignor's Interest Aug 21, 2023
From: NANDI, INDRANIL; HIPPALGAONKAR, KETAN; VANDSE, SUNIL; VACHHANI, RISH J.
To: VERTICE PHARMA, LLC
Reel/Frame 064646/0868 →
Assignment of Assignor's Interest Aug 21, 2023
From: VISTAPHARM, LLC
To: AZURITY PHARMACEUTICALS, INC.
Reel/Frame 064646/0881 →
Assignment of Assignor's Interest Aug 21, 2023
From: VISTAPHARM, LLC
To: AZURITY PHARMACEUTICALS, INC.
Reel/Frame 064646/0903 →
Confirmatory Grant of Security Interest in United States Patents Mar 17, 2025
From: ARBOR PHARMACEUTICALS, LLC; AZURITY PHARMACEUTICALS, INC.; AZURITY PHARMACEUTICALS IRELAND LIMITED; SILVERGATE PHARMACEUTICALS, INC.
To: HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 070531/0487 →